Novo Nordisk has reported new data with its long-acting human growth hormone (hGH) product Sogroya, showing it is at least as effective as its older drug Norditropin in various paediatric growth ...

We recently published a list of 15 Best Stocks to Buy According to Jim Simons’ Renaissance Technologies In this article, we are going to take a look at where Novo Nordisk A/S (NYSE:NVO ...

Novo Nordisk (NVO) is headquartered in Bagsvaerd, and is in the Medical sector. The stock has seen a price change of -21.47% since the start of the year. The drugmaker is currently shelling out a ...

Novo Nordisk has made its smart insulin pens ... The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

HMS Sultan has raised more than £3,000 for charity through a special challenge. The Royal Navy base in Gosport organised a 24-hour event to commemorate the 80th anniversary of VE Day and raise ...

The best Android smartwatches work with a variety of Android handsets thanks to their excellent cross-compatibility. Hailing from a wide variety of Android OEMs, there's an Android smartwatch for ...

In addition to eliciting greater weight loss than Novo Nordisk’s Wegovy, Eli Lilly’s Zepbound does not come at the expense of safety, according to newly released comprehensive tolerability ...

Novo Nordisk has officially begun building a $1.8 billion production facility for diabetes medicines at its Clayton site that will create 700 high-paying jobs, doubling its workforce there. The ...